Literature DB >> 19770714

Iris melanoma arising from sector congenital ocular melanocytosis in a child.

Jerry A Shields1, Carol L Shields, Richard Davidson, Ralph C Eagle.   

Abstract

PURPOSE: To report a clinicopathologic correlation of a melanoma arising from iris component of ocular melanocytosis in a child.
METHODS: A 13-year-old boy developed a progressive iris nodule arising from sector iris pigmentation that was a component of congenital ocular melanocytosis involving the iris, ciliary body and choroid. The tumor was examined clinically and with ultrasound biomicroscopy (UBM), removed by peripheral iridocyclectomy, and studied histopathologically.
RESULTS: Clinically, the pigmented nodule was 3 mm in diameter, located within the sector iris pigmentation, and was 2.4 mm in thickness as measured by UBM. Histopathologically, it was composed predominately of spindle B melanoma cells with adjacent spindle and dendritic melanocytes compatible with iris melanocytosis.
CONCLUSION: Although highly unusual, melanoma can arise in the sector iris pigmentation that is often a component of congenital ocular melanocytosis. Even young patients with ocular melanocytosis should be examined periodically for development of melanoma in the ciliary body and choroid.

Entities:  

Mesh:

Year:  2009        PMID: 19770714     DOI: 10.1097/ICO.0b013e31819b3384

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  2 in total

1.  Primary Episcleral Melanoma Consistent with Uveal Melanoma Mutations Treated by Excision and Gamma Knife Stereotactic Radiosurgery.

Authors:  Spencer T Langevin; Eileen Chang; Tony J C Wang; Israel Deutsch; Marc Otten; Brian P Marr
Journal:  Ocul Oncol Pathol       Date:  2019-09-18

2.  Prevalence of ocular and oculodermal melanocytosis in Spanish population with uveal melanoma.

Authors:  E Carreño; M A Saornil; C Garcia-Alvarez; F Lopez-Lara; J M De Frutos-Baraja; A Almaraz
Journal:  Eye (Lond)       Date:  2011-10-21       Impact factor: 3.775

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.